eFFECTOR Therapeutics, Inc. Common Stock
EFTR
EFTR was delisted on the 2nd of July, 2024.
33 hedge funds and large institutions have $20.2M invested in eFFECTOR Therapeutics, Inc. Common Stock in 2023 Q2 according to their latest regulatory filings, with 10 funds opening new positions, 2 increasing their positions, 3 reducing their positions, and 3 closing their positions.
1,771% more call options, than puts
Call options by funds: $393K | Put options by funds: $21K
233% more first-time investments, than exits
New positions opened: 10 | Existing positions closed: 3
103% more capital invested
Capital invested by funds: $9.94M → $20.2M (+$10.2M)
50% more funds holding in top 10
Funds holding in top 10: 2 → 3 (+1)
27% more funds holding
Funds holding: 26 → 33 (+7)
33% less repeat investments, than reductions
Existing positions increased: 2 | Existing positions reduced: 3
Top Buyers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
Renaissance Technologies
New York
|
+$498K |
| 2 |
Two Sigma Investments
New York
|
+$55.1K |
| 3 |
HF
HRT Financial
New York
|
+$21K |
| 4 |
XT
XTX Topco
George Town,
Cayman Islands
|
+$19.5K |
| 5 |
Morgan Stanley
New York
|
+$12.2K |
Top Sellers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
BlackRock
New York
|
-$35.5K |
| 2 |
Susquehanna International Group
Bala Cynwyd,
Pennsylvania
|
-$10.5K |
| 3 |
TSS
Two Sigma Securities
New York
|
-$8.69K |
| 4 |
UBS Group
Zurich,
Switzerland
|
-$7.56K |
| 5 |
GSC
Ground Swell Capital
Folly Beach,
South Carolina
|
-$4.23K |
| Name | Holding | Trade Value |
Shares Change |
Change in Stake |
|
|---|---|---|---|---|---|
26
Simplex Trading
Chicago,
Illinois
| $8K | +$6.84K | +405 | New |
|
|
VF
27
Virtu Financial
New York
| $8K | +$6.86K | +406 | New |
|
28
Osaic Holdings
Scottsdale,
Arizona
| $1.33K | – | – | – |
|
|
IGWM
29
ICA Group Wealth Management
Denver,
Colorado
| $914 | +$743 | +44 | New |
|
|
30
BlackRock
New York
| $460 | -$35.5K | -2,101 | -99% |
|
31
Bank of America
Charlotte,
North Carolina
| $83 | – | – | – |
|
32
Wells Fargo
San Francisco,
California
| $66 | – | – | – |
|
|
TSS
33
Two Sigma Securities
New York
| – | -$8.69K | -985 | Closed |
|
|
34
UBS Group
Zurich,
Switzerland
| – | -$7.56K | -857 | Closed |
|
|
GSC
35
Ground Swell Capital
Folly Beach,
South Carolina
| – | -$4.23K | -470 | Closed |
|
36
Royal Bank of Canada
Toronto,
Ontario, Canada
| – | +$270 | +16 | New |
|
EFTR Hedge Fund Activity: Q2 2023 in Review
33 of the 6,369 institutional investors tracked by Wall St. Rank reported a position in eFFECTOR Therapeutics, Inc. Common Stock (EFTR) for Q2 2023, worth a combined $20.2M — up 103% from $9.94M a quarter earlier.
Buyers outnumbered sellers: 10 funds opened new EFTR positions and 3 closed out — a net gain of 7 holders — while 2 added to existing stakes and 3 trimmed.
The largest buyer was Renaissance Technologies, adding an estimated $498K. The largest seller was BlackRock, cutting an estimated $35.5K.
- 33 institutional investors held eFFECTOR Therapeutics, Inc. Common Stock (EFTR) as of Q2 2023, up from 26 in Q1 2023.
- Funds reported $20.2M of eFFECTOR Therapeutics, Inc. Common Stock stock for Q2 2023, up 103% quarter-over-quarter.
- 10 funds opened new eFFECTOR Therapeutics, Inc. Common Stock positions in Q2 2023 and 3 closed out, a net change of +7 holders.
- The largest eFFECTOR Therapeutics, Inc. Common Stock buyer in Q2 2023 was Renaissance Technologies, an estimated $498K added.
- The largest eFFECTOR Therapeutics, Inc. Common Stock seller in Q2 2023 was BlackRock, an estimated $35.5K sold.
Based on aggregated 13F filings for Q2 2023.